New Delhi: The United States of America (USA) will be imposing 100% Tariff on the pharmaceutical products from October 01, 2025.
US President Donald Trump informed on Truth Social, “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. “IS BUILDING” will be defined as, “breaking ground” and/or “under construction.” There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started. Thank you for your attention to this matter!”
India exports about $10 billion worth of pharma products to the US every year. However, this tariff imposition applies only to patented and branded products supplied to the USA and is not applicable to generic medicines. India hardly exports branded drugs and largely supplies generic drugs to the US. .
